Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Associations between primary syringe source and HCV seroprevalence: New England (NH, VT, MA), 2018–2019

From: HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England

Primary Syringe Source (Past 30 days)

Crude PR (95% CI)

Adjusted PRa,b (95% CI)

Direct SSP

0.92 (0.76–1.12)

0.89 (0.75–1.04)

Pharmacy

0.90 (0.79–1.02)

0.85 (0.73–1.00)

Indirect SSP

0.98 (0.83–1.15)

0.96 (0.82–1.13)

Other Source

reference

reference

  1. PR Prevalence ratio; CI Confidence interval
  2. aAdjusted for age, gender, race, sexual orientation, incarceration, homelessness, years injecting, injection frequency, inject multiple times per sitting, inject heroin, inject cocaine, inject meth, inject speedball/screwball, ever received medication for opioid use disorder
  3. bn = 375
Back to article page

Addiction Science & Clinical Practice

ISSN: 1940-0640